Brought to you by 
Nycomed is buying Altana's pharma business for €4.5bn
25 Sep 2006
Executive Summary
European specialty pharma Nycomed Group has acquired Altana AG's pharmaceuticals subsidiary Altana Pharma AG for €4.215bn ($5.346bn) plus another €3mm price adjustment at closing (for net cash on hand and working capital).
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- OTC, Consumer
- Radiopharmaceuticals, Contrast Agents
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Nycomed is buying Altana's pharma business for €4.5bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice